In the BioHarmony Drug Report Database

"Preview" Icon

Agalsidase alfa

Replagal (agalsidase alfa) is an enzyme pharmaceutical. Agalsidase alfa was first approved as Replagal on 2001-08-03. It has been approved in Europe to treat fabry disease.

 

Trade Name

 

Replagal
 

Common Name

 

agalsidase alfa
 

ChEMBL ID

 

CHEMBL2108214
 

Indication

 

fabry disease
 

Drug Class

 

Enzymes

Image (chem structure or protein)

Agalsidase alfa structure rendering